O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA LUIS ANTONIO DÍAZ PIGA; Carolina Aguilera; Gustavo Ayares; Francisco Idalsoaga; Mauricio Pizarro; Fernando Javier Barreyro; Sebastián Marciano; Jorge Martínez Morales; Cristiane Villela-Nogueira; Nathalie Leite; Claudia Alves Couto; Rafael Theodoro; Mísia Joyner de Sousa Dias Monteiro; Mario G. Pessoa; Mario Reis Alvares-da-Silva; Fátima Higuera de la Tijera; Adelina Lozano; Pedro Montes; Graciela Castro-Narro; Constanza D. Sabate; Manuel Mendizabal; Francisco Barrera; Daniel Cabrera; Mazen Noureddin; Naim Alkhouri; Winston Dunn; Zobair Younossi; Jeffrey V. Lazarus; Rohit Loomba; Claudia Pinto Marques Souza de Oliveira; Adrian Gadano; Marco Arrese; Juan Pablo Arab;

P-16 UNLOCKING S-PINDOLOL'S POTENTIAL FOR MASLD: BENEFICIAL EFFECTS ON MUSCLE MASS AND FUNCTION AND LIVER HISTOLOGY IN WESTERN- DIET FED MICE Daniel Cabrera; Loreto Aguilar; Faride Saud; Lisbell Estrada; Marcelo Andia; Marco Arrese; Juan Pablo Arab; Luis Antonio Diaz; Francisco Barrera; Rene Baudrand; Claudio Cabello-Verrugio;

OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles MARIA AYALA VALVERDE; Jorge Arnold Alvarez; Gustavo Ayares; Francisco Barrera; Daniel Cabrera; Luis Antonio Diaz; Juan Pablo Arab; Ibon Martinez-Arranz; Cristina Alonso; Jesús M. Bañales; Marco Arrese;